The researchers found a molecule called beta-arrestin that can cause bone to form and then discovered a way to reduce the loss of bone, while stimulating bone growth.
The research was reported in the inaugural issue of the journal Science Translational Medicine.
Read UPI’s report on a new bone-growing therapy.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
